266 related articles for article (PubMed ID: 18096310)
21. Tumor necrosis factor alpha receptor- and Fas-associated FLASH inhibit transcriptional activity of the glucocorticoid receptor by binding to and interfering with its interaction with p160 type nuclear receptor coactivators.
Kino T; Chrousos GP
J Biol Chem; 2003 Jan; 278(5):3023-9. PubMed ID: 12477726
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid/glucocorticoid receptor inhibition of surfactant protein-A (SP-A) gene expression in lung type II cells is mediated by repressive changes in histone modification at the SP-A promoter.
Islam KN; Mendelson CR
Mol Endocrinol; 2008 Mar; 22(3):585-96. PubMed ID: 18079322
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
Ki SH; Cho IJ; Choi DW; Kim SG
Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
[TBL] [Abstract][Full Text] [Related]
24. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.
Martens C; Bilodeau S; Maira M; Gauthier Y; Drouin J
Mol Endocrinol; 2005 Apr; 19(4):885-97. PubMed ID: 15591535
[TBL] [Abstract][Full Text] [Related]
25. Negative glucocorticoid receptor response elements and their role in glucocorticoid action.
Dostert A; Heinzel T
Curr Pharm Des; 2004; 10(23):2807-16. PubMed ID: 15379669
[TBL] [Abstract][Full Text] [Related]
26. The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism.
De Martino MU; Bhattachryya N; Alesci S; Ichijo T; Chrousos GP; Kino T
Mol Endocrinol; 2004 Apr; 18(4):820-33. PubMed ID: 14739255
[TBL] [Abstract][Full Text] [Related]
27. G protein beta interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus.
Kino T; Tiulpakov A; Ichijo T; Chheng L; Kozasa T; Chrousos GP
J Cell Biol; 2005 Jun; 169(6):885-96. PubMed ID: 15955845
[TBL] [Abstract][Full Text] [Related]
28. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity.
Karmakar S; Jin Y; Nagaich AK
J Biol Chem; 2013 Aug; 288(33):24020-34. PubMed ID: 23814048
[TBL] [Abstract][Full Text] [Related]
29. Studies on the mechanism of glucocorticoid-mediated repression from a negative glucocorticoid response element from the bovine prolactin gene.
Subramaniam N; Cairns W; Okret S
DNA Cell Biol; 1997 Feb; 16(2):153-63. PubMed ID: 9052736
[TBL] [Abstract][Full Text] [Related]
30. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for inhibition of the histone chaperone activity of SET/TAF-Iβ by cytochrome c.
González-Arzola K; Díaz-Moreno I; Cano-González A; Díaz-Quintana A; Velázquez-Campoy A; Moreno-Beltrán B; López-Rivas A; De la Rosa MA
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9908-13. PubMed ID: 26216969
[TBL] [Abstract][Full Text] [Related]
32. Effect of leucine-to-methionine substitutions on the diffraction quality of histone chaperone SET/TAF-Ibeta/INHAT crystals.
Senda M; Muto S; Horikoshi M; Senda T
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Oct; 64(Pt 10):960-5. PubMed ID: 18931446
[TBL] [Abstract][Full Text] [Related]
33. Chromatin immunoprecipitation scanning identifies glucocorticoid receptor binding regions in the proximal promoter of a ubiquitously expressed glucocorticoid target gene in brain.
van der Laan S; Sarabdjitsingh RA; Van Batenburg MF; Lachize SB; Li H; Dijkmans TF; Vreugdenhil E; de Kloet ER; Meijer OC
J Neurochem; 2008 Sep; 106(6):2515-23. PubMed ID: 18643788
[TBL] [Abstract][Full Text] [Related]
34. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
35. The ligand binding domain controls glucocorticoid receptor dynamics independent of ligand release.
Meijsing SH; Elbi C; Luecke HF; Hager GL; Yamamoto KR
Mol Cell Biol; 2007 Apr; 27(7):2442-51. PubMed ID: 17261597
[TBL] [Abstract][Full Text] [Related]
36. Role of steroid receptor coactivators in glucocorticoid and transforming growth factor beta regulation of plasminogen activator inhibitor gene expression.
Li G; Heaton JH; Gelehrter TD
Mol Endocrinol; 2006 May; 20(5):1025-34. PubMed ID: 16423881
[TBL] [Abstract][Full Text] [Related]
37. Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment.
Jee YK; Gilmour J; Kelly A; Bowen H; Richards D; Soh C; Smith P; Hawrylowicz C; Cousins D; Lee T; Lavender P
J Biol Chem; 2005 Jun; 280(24):23243-50. PubMed ID: 15826950
[TBL] [Abstract][Full Text] [Related]
38. SKOV3 cells containing a truncated ARID1a protein have a restricted genome-wide response to glucocorticoids.
Stubbs FE; Birnie MT; Biddie SC; Lightman SL; Conway-Campbell BL
Mol Cell Endocrinol; 2018 Feb; 461():226-235. PubMed ID: 28942102
[TBL] [Abstract][Full Text] [Related]
39. Cryptic chromosome 9q34 deletion generates TAF-Ialpha/CAN and TAF-Ibeta/CAN fusion transcripts in acute myeloid leukemia.
Rosati R; La Starza R; Barba G; Gorello P; Pierini V; Matteucci C; Roti G; Crescenzi B; Aloisi T; Aversa F; Martelli MF; Mecucci C
Haematologica; 2007 Feb; 92(2):232-5. PubMed ID: 17296573
[TBL] [Abstract][Full Text] [Related]
40. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
Chatterjee VK; Madison LD; Mayo S; Jameson JL
Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
